Nonetheless, copeptin was independently associated with an increased risk of incident stroke in older men with diabetes [HR = 2.34 (95% CI 1.04–5.27)] (217), indicating that the vasopressin system might be a therapeutic target with effects on stroke risk in this population. The gene discussed is AVP; the disease is stroke disorder.